Literature DB >> 17047914

From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?

L A Distiller, B I Joffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17047914     DOI： 10.1007/s00125-006-0454-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.

Authors:  A Mohn; S Strang; K Wernicke-Panten; A M Lang; J A Edge; D B Dunger
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

2.  Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.

Authors:  Ian W Gallen; Celia Carter
Journal:  Diabetes Care       Date:  2003-12       Impact factor: 19.112

Review 3.  Insulins today and beyond.

Authors:  D R Owens; B Zinman; G B Bolli
Journal:  Lancet       Date:  2001-09-01       Impact factor: 79.321

4.  Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

Authors:  J Rosenstock; S L Schwartz; C M Clark; G D Park; D W Donley; M B Edwards
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

5.  Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes.

Authors:  T R Pieber; I Eugène-Jolchine; E Derobert
Journal:  Diabetes Care       Date:  2000-02       Impact factor: 19.112

Review 6.  Intensive insulin regimens: evidence for benefit.

Authors:  R G Bretzel
Journal:  Int J Obes Relat Metab Disord       Date:  2004-09
  6 in total
  4 in total

1.  The insulin dilemma in resource-limited countries. A way forward?

Authors:  G V Gill; J S Yudkin; H Keen; D Beran
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

2.  Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic? Diabetologia 49:2793-2794.

Authors:  D S H Bell
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

3.  In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes.

Authors:  Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le Compte; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05

Review 4.  Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?

Authors:  David S H Bell
Journal:  Drugs       Date:  2007       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.